Home Cart Sign in  
Chemical Structure| 346692-04-4 Chemical Structure| 346692-04-4

Structure of DC260126
CAS No.: 346692-04-4

Chemical Structure| 346692-04-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DC260126 is antagoniat of free fatty acid receptor 1 (FFA1/GPR40) and inhibits FFA-induced the increase of intracellular Ca2+ level.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DC260126

CAS No. :346692-04-4
Formula : C16H18FNO2S
M.W : 307.38
SMILES Code : O=S(C1=CC=C(F)C=C1)(NC2=CC=C(CCCC)C=C2)=O
MDL No. :MFCD00784423
InChI Key :CNGHPXKWPGIDSK-UHFFFAOYSA-N
Pubchem ID :2843133

Safety of DC260126

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of DC260126

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
pancreatic acinar AR42J cells 10 μM 2 h DC260126 suppressed the inhibitory effect of DHA on cerulein-induced zymogen activation Genes Nutr. 2020 Mar 23;15(1):6.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Db/db mice Obese diabetic model Tail vein injection 10 mg/kg Once daily for 21 days DC260126 significantly inhibited glucose stimulated insulin secretion, reduced blood insulin level and improved insulin sensitivity. Moreover, DC260126 reduced the proinsulin/insulin ratio and the apoptotic rate of pancreatic β-cells remarkably. PLoS One. 2013 Jun 11;8(6):e66744
Mice Wildtype (WT), caspase-1 knockout (KO) and/or IL-1 receptor 1 (IL-1R1) KO mice Intraperitoneal injection 10 mg/kg Administered immediately following a 24-hour fasting period, before a 2-hour refeeding. DC260126 mitigated learning impairment associated with HFD refeeding while blocking caspase-1 activation in the BLp. Metabolism. 2020 Jan;102:153989

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.33mL

16.27mL

3.25mL

1.63mL

32.53mL

6.51mL

3.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories